Ethicon, Allergan, Covidien Battle for Share of $4.1 Billion Laparoscopic Surgery Market with Gastric Band, Direct Energy, Ultra

U.S. Obesity Epidemic Fuels Gastric Band Sales Growth to Double-Digit Rates

VANCOUVER, Sept. 13, 2011 /PRNewswire/ - According to a new report series by iData Research (, the leading global authority in medical device market research, the U.S. laparoscopic device market experienced strong growth in 2011, reaching over $4.1 billion. Ethicon, Allergan and Covidien battled for control of this market, particularly in the gastric-band, direct-energy and ultrasonic device segments. Technological advancements in these areas will fuel double-digit growth and drive the overall laparoscopic device market to reach sales of approximately $7.5 billion by 2018.

"Obesity affected over 60 million Americans in 2011 and the rising demand for bariatric surgery to enable weight-loss has driven the gastric-band segment to become the fastest-growing in the laparoscopic device market," says Dr. Kamran Zamanian, CEO of iData. "In addition, the recent FDA approval of LAP-BAND® by Allergan for patients with lower BMIs, is expected to further fuel the market to more than double in value by 2018. The expected approval of a gastric-band designed for adolescents will also expand the potential patient pool."

The report states that direct-energy devices used in electrosurgery to cut, coagulate, desiccate or fulgurate tissue are expected to reach over $2 billion in annual sales by 2018. Ultrasonic devices, which use lower-temperatures and vibrations to grasp and cut tissue, are also expected to see strong growth through 2018. These segments will be driven by disposable sales, such as Ethicon's HARMONIC®, that offer convenience and increased surgeon confidence in sterility. In addition, sales of multi-functional devices, such as Covidien's LigaSure Advance™ which reduce operative time, are expected to see rapid-growth.

"By 2018, we will also see a dramatic rise in single-port surgeries," says Dr. Zamanian. "This technique is reported to have less post-operative pain, faster recovery times and reduced scarring."

For more information, register free at:

iData's 2-report series on the U.S. and European "Markets for Laparoscopic Devices 2012" covers: laparoscopes, gastric-bands, access-devices, hand-instruments, insufflation, suction-irrigation, direct-energy, ultrasonic, hand-assisted,  female-sterilization and closure devices.

About iData Research

iData Research ( is an international market research and consulting group focused on providing market intelligence for top medical device companies. iData covers research in: laparoscopy, endoscopy, wound-management and more.

SOURCE iData Research Inc.

Suggested Articles

With U.S. presidential and congressional campaigns in full swing, it’s not just Americans anxiously awaiting the results of the upcoming elections.

Sun Pharma has recalled one lot of its generic metformin after finding high levels of the probable carcinogen NDMA in tested lots.

Six months after WHO declared a pandemic, the list of drugs proven to work against the virus remains short. Now, Fujifilm has added its drug Avigan.